These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Secretary of Health and Human Services Robert F. Kennedy Jr. attends President Donald Trump's address to a joint session of Congress at the U.S. Capitol on March 4, 2025, in Washington, D.C. Win ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

Reports Q4 revenue $22.09M, consensus $25.25M. “2024 was a pivotal year for UroGen with achievements across our commercial business and pipeline,” said Liz Barrett, president and CEO of UroGen.

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Editor’s note: This story has been updated to correct the individual who admitted to insider trading. SAN DIEGO (FOX 5/KUSI) — The former vice president of Acadia Pharmaceuticals Inc ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...

Cash Equivalents and Short-term Investments: $238 million as of December 31, 2024, compared to $170 million as of December 30, 2023. Revenue: $26.6 million in Q4 2024 and $31.1 million for the ...

The health of America is in jeopardy. Doctors do not have access to the full safety and effectiveness data for the treatments we rely upon. Pharmaceutical companies control and hide information ...